2uu7

Revision as of 21:05, 18 December 2007 by OCA (talk | contribs) (New page: left|200px<br /><applet load="2uu7" size="450" color="white" frame="true" align="right" spinBox="true" caption="2uu7, resolution 3.00Å" /> '''CRYSTAL STRUCTURE OF...)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

CRYSTAL STRUCTURE OF APO GLUTAMINE SYNTHETASE FROM DOG (CANIS FAMILIARIS)

File:2uu7.gif


2uu7, resolution 3.00Å

Drag the structure with the mouse to rotate

OverviewOverview

Glutamine synthetase (GS) catalyzes the ligation of glutamate and ammonia, to form glutamine, with concomitant hydrolysis of ATP. In mammals, the, activity eliminates cytotoxic ammonia, at the same time converting, neurotoxic glutamate to harmless glutamine; there are a number of links, between changes in GS activity and neurodegenerative disorders, such as, Alzheimer's disease. In plants, because of its importance in the, assimilation and re-assimilation of ammonia, the enzyme is a target of, some herbicides. GS is also a central component of bacterial nitrogen, metabolism and a potential drug target. Previous studies had investigated, the structures of bacterial and plant GSs. In the present publication, we, report the first structures of mammalian GSs. The apo form of the canine, enzyme was solved by molecular replacement and refined at a resolution of, 3 A. Two structures of human glutamine synthetase represent complexes, with: a) phosphate, ADP, and manganese, and b) a phosphorylated form of, the inhibitor methionine sulfoximine, ADP and manganese; these structures, were refined to resolutions of 2.05 A and 2.6 A, respectively. Loop, movements near the active site generate more closed forms of the, eukaryotic enzymes when substrates are bound; the largest changes are, associated with the binding of the nucleotide. Comparisons with earlier, structures provide a basis for the design of drugs that are specifically, directed at either human or bacterial enzymes. The site of binding the, amino acid substrate is highly conserved in bacterial and eukaryotic GSs, whereas the nucleotide binding site varies to a much larger degree. Thus, the latter site offers the best target for specific drug design., Differences between mammalian and plant enzymes are much more subtle, suggesting that herbicides targeting GS must be designed with caution.

About this StructureAbout this Structure

2UU7 is a Single protein structure of sequence from Canis lupus familiaris with MG and CL as ligands. Active as Glutamate--ammonia ligase, with EC number 6.3.1.2 Known structural/functional Sites: , , , , , , , , , , , , , , , , , , , , , , , , , , , , and . Full crystallographic information is available from OCA.

ReferenceReference

Crystal Structures of Mammalian Glutamine Synthetases Illustrate Substrate-Induced Conformational Changes and Provide Opportunities for Drug and Herbicide Design., Krajewski WW, Collins R, Holmberg-Schiavone L, Jones TA, Karlberg T, Mowbray SL, J Mol Biol. 2007 Oct 17;. PMID:18005987

Page seeded by OCA on Tue Dec 18 20:15:33 2007

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA